AlphaQuest’s Inhibrx INBX Stock Holding History

AlphaQuest’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,192	Closed	-$173K	–	977
2025 Q4	$173K	Buy	+2,192	New	+$149K	0.01%	1519
2025 Q1	–	Sell	-1	Closed	-$15	–	2047
2024 Q4	$15	Sell	1 -2	-67%	-$30	﹤0.01%	1663
2024 Q3	$47	Hold	3	–	–	﹤0.01%	1838
2024 Q2	$43	Buy	+3	New	+$47	﹤0.01%	1494

Other funds holding INBX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AlphaQuest's INBX Position: Q1 2026 in Review

AlphaQuest sold out of Inhibrx (INBX) in Q1 2026, closing a stake of 2,192 shares — an estimated $173K sold.

AlphaQuest first reported a position in INBX in Q2 2024 and held it in 4 quarters. The position peaked at $173K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

AlphaQuest reported no remaining Inhibrx position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 2,192 Inhibrx shares in Q1 2026, an estimated $173K.
AlphaQuest first reported a position in Inhibrx in Q2 2024 and held it in 4 quarters.
AlphaQuest's Inhibrx position peaked at $173K in Q4 2025.
135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.